-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE THERAPEUTICS - PLANS PHASE 1/2 CLINICAL TRIAL OF ELRAGLUSIB ORAL TABLET IN Q1 2027

Reuters·11/02/2026 13:05:39